Maxim Group Maintains Medicus Pharma(MDCX.US) With Buy Rating, Maintains Target Price $10
Medicus Pharma Ltd Poised for Growth: Buy Rating Reaffirmed Amid Promising Developments and Upcoming Catalysts
Maxim Group Initiates Medicus Pharma(MDCX.US) With Buy Rating, Announces Target Price $10
Medicus Pharma Ltd: Innovative D-MNA Product Positions Company for Success With Favorable Buy Rating
Brookline Capital Initiates Medicus Pharma(MDCX.US) With Buy Rating, Announces Target Price $12
Medicus Pharma Initiated With a Buy at Brookline
Medicus Pharma Analyst Ratings
Maxim Group Initiates Coverage On Medicus Pharma With Buy Rating, Announces Price Target of $10
Maxim Group Initiates Medicus Pharma(MDCX.US) With Buy Rating, Announces Target Price $10